Crossject is revolutionizing needle free injection

Colonne 1

Crossject is revolutionizing the administration of well-established, clinically-proven treatments and bringing unprecedented advantages to patients with its innovative, needle-free auto-injector ZENEO®. The prefilled, single-use device propels the medicine through the skin in only 50 milliseconds. Crossject currently has eight ZENEO® solutions in advanced stages of development, seven of which are for emergency situations.  

Zeneo illustration


Our news

Image de l'actualité

ZENEO® receives the JANUS

Résumé de l'actualité

Crossject is proud to announce that ZENEO® received the 2017 JANUS Prospective award from the French Institute of Design. 

Image de l'actualité
Conference room

Conference calendar

Résumé de l'actualité

Starting in autumn, Crossject will be attending renowned international conferences in Europe and the United States.


Financial news: Financial calendar 2018

Sommaire ou résumé

Crossject announces its Financial calendar 2018.